Prevention of macrophage-related inflammatory diseases by allergina

Conway, J. G., Andrews, R. C., Beaudet, B., Bickett, D. M., Boncek, V., Brodie, T. A., Clark, R. L., Crumrine, R. C., Leenitzer, M. A., McDougald, D. L., Han, B., Hedeen, K., Lin, P., Milla, M., Moss, M., Pink, H., Rabinowitz, M. H., Tippin, T., Scates, P. W., Selph, J., Stimpson, S. A., Warner, J., and Becherer, J. D., Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases.J. Pharmacol. Exp. Ther., 298, 900–908 2001.

Gongora, L., Manez, S., Giner, R. M., Recio, M. C., and Rios, J. L., On the activity of trifluoperazine and palmitoylcarnitine in mice: delayed hypersensitivity models.Life Sci., 66, L183–188 2000.

Gorgun, G., Miller, K. B., and Foss, F. M., Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease.Blood, 100, 941–947 2002.

Han, S. B., Park, S. H., Jeon, Y. J., Kim, Y K., Kim, H. M., and Yang, K. H., Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis.J. Pharmacol. Exp. Ther., 299, 415–425 2001.

Jeong, H. J., Hong, S. H., Kim, S. C., Park, E. J., Jang, C. H., Kim, K. S., and Kim, H. M., Effects of Allergina on the treatment of otitis media with effusions.Inflammation, 26, 89–95 2002.

Jeong, H. J., Jung, S. W., Kim, K. S., Lim, J. P., Park, E. J., Hwang, W. J., Jang, C. H., and Kim, H. M., Effect of allergina on mast cell-mediated allergic reactions.Immunopharmacol. Immunotoxicol., 23, 627–637 2001.

Lu, Y., Sakamaki, S., Kuroda, H., Kusakabe, T., Konuma, Y., Akiyama, T., Fujimi, A., Takemoto, N., Nishiie, K., Matsunaga, T., Hirayama, Y., Kato, J., Kon, S., Kogawa, K., and Niitsu, Y., Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603.Blood, 97, 1123–1130 2001.

Luross, J. A. and Williams, N. A., The genetic and immunopathological processes underlying collagen-induced arthritis.Immunol., 103, 407–416 2001.

Okamoto, I., Iwaki, K., Koya-Miyata, S., Tanimoto, I., Kohno, K., Ikeda, M., and Kurimoto, M., The flavonoid Kaempferol suppresses the graft-versus-host reaction by inhibiting type 1 cytokine production and CD8+ T cell engraftment.Clin. Immunol., 103, 132–144 2002.

Taylor, P. A., Friedman, T. M., Korngold, R., Noelle, R. J., and Blazar, B. R., Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell.Blood, 99, 4601–609 2002.

Wagner, J. E., Donnenberg, A. D., Noga, S. J., Cremo, C. A., Gao, I. K., Yin, H. J., Vogelsang, G. B., Rowley, S., Saral, R., and Santos, G. W., Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trial.Blood, 72, 1168–1176 1988.

Weisdorf, D., Haake, R., Blazar, B., Miller, W., McGlave, P., Ramsay, N., Kersey, J., and Filipovich, A., Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome.Blood, 75, 1024–1030 1990.